Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.
GHTC joined 103 organizations in endorsing a letter to House and Senate leadership urging them to complete final negotiations on the fiscal year (FY) 2020 Defense Appropriations Act and pass the bill in order to protect funding for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs—which have historically supported research on global health issues like malaria and tuberculosis.
GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”
Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).
Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.
The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.
Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.
This legislation is an important step forward in strengthening our nation’s preparedness against global disease threats. We applaud the Administration and Congress for recognizing that protecting our nation’s health requires deploying BARDA’s unique capabilities to combat all hazards—not only chemical, biological, radiological and nuclear threats, but naturally occurring health threats as well.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).
A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill.
The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development.
The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.
GHTC joined 103 organizations in endorsing a letter to House and Senate leadership urging them to complete final negotiations on the fiscal year (FY) 2020 Defense Appropriations Act and pass the bill in order to protect funding for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs—which have historically supported research on global health issues like malaria and tuberculosis.
GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”
GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan.
GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.
GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.
